Regeneron Pharmaceuticals (REGN) EBT (2009 - 2026)
Regeneron Pharmaceuticals (REGN) reported EBT of $1.53 billion for Q2 2026, up 0.6% from $1.52 billion a year earlier and up 83.8% from the prior quarter.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) EBT (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Regeneron Pharmaceuticals' EBT came in at $5.17 billion, up 6.0% year-over-year; for FY2025, it came in at $5.23 billion, up 9.4% from FY2024.
- EBT has a five-year compound annual growth rate of 6.5% (FY2020 to FY2025).
- By year, EBT came in at $4.78 billion in FY2024 (+13.8%), $4.2 billion in FY2023 (-13.6%), $4.86 billion in FY2022 (-47.9%) and $9.33 billion in FY2021 (+144.7%).
- Five-year quarterly EBT spans a low of $700.7 million in Q1 2024 and a high of $2.5 billion in Q4 2021.
- Year over year, EBT gained in five of the last eight quarters, with growth averaging 7.5%.
- The high point for year-over-year EBT in five years was Q4 2021 (growth of 104.4%); the low point was Q2 2022 (a decline of 74.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $831.2 million (Q1 2026), $1.04 billion (Q4 2025) and $1.76 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 9.25 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 6.75 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 4.28 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | -683.00 Mn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 4.27 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 2.80 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 2.77 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | -10.25 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | -653.00 Mn |
| 10 | Regeneron Pharmaceuticals | 81.27 Bn | 47.47 Bn | 3.71 Bn | 1.53 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.53 Bn |
| Mar 31, 2026 | 831.20 Mn |
| Dec 31, 2025 | 1.04 Bn |
| Sep 30, 2025 | 1.76 Bn |
| Jun 30, 2025 | 1.52 Bn |
| Mar 31, 2025 | 905.00 Mn |
| Dec 31, 2024 | 958.10 Mn |
| Sep 30, 2024 | 1.49 Bn |
| Jun 30, 2024 | 1.63 Bn |
| Mar 31, 2024 | 700.70 Mn |
| Dec 31, 2023 | 1.15 Bn |
| Sep 30, 2023 | 1.11 Bn |
| Jun 30, 2023 | 1.08 Bn |
| Mar 31, 2023 | 858.00 Mn |
| Dec 31, 2022 | 1.32 Bn |
| Sep 30, 2022 | 1.51 Bn |
| Jun 30, 2022 | 963.20 Mn |
| Mar 31, 2022 | 1.06 Bn |
| Dec 31, 2021 | 2.50 Bn |
| Sep 30, 2021 | 1.82 Bn |
API Access
Regeneron Pharmaceuticals EBT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt&ticker=REGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();